跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,326 条关于
“AVO-100”
全部
16,326
临床试验
6,474
药物
4,705
机构
149
资讯
4,998
去年
AAVivo Advances In Vivo CAR-T Platform with PACE Technology for Precision Gene Delivery
3年前
Acalabrutinib, Obinutuzumab, and Venetoclax Triplet Shows Promise in High-Risk CLL
3年前
Acalabrutinib, Venetoclax, and Obinutuzumab Show Durable Responses in CLL
5年前
Acalabrutinib, Venetoclax, and Obinutuzumab Triplet Shows High Efficacy in CLL
2年前
Acalabrutinib, Venetoclax, and Obinutuzumab Show Promise in High-Risk CLL
去年
AMPLIFY Trial: Acalabrutinib and Venetoclax Show Promise in Treatment-Naive CLL
去年
Acalabrutinib Plus Venetoclax Significantly Improves PFS in Untreated CLL
去年
Triplet Therapy Shows Promise in High-Risk Chronic Lymphocytic Leukemia
去年
Alteplase Shows Benefit in MRI-Guided Thrombolysis for Stroke Patients with Vessel Occlusion
2个月前
Synergy Disc Reaches 100 U.S. Cases in 100 Days Following FDA Approval, Advancing Motion-Preserving Cervical Disc Replacement
第 1 页,共 500 页
上一页
下一页